VAISHALI PHARMA Financial Statement Analysis
|
||
|
The Revenues of VAISHALI PHARMA have decreased by -8.12% YoY .
The Earnings Per Share (EPS) of VAISHALI PHARMA has increased by 63.87 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
VAISHALI PHARMA Last 5 Annual Financial Results
[NSE : VAISHALI]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹70 Cr | ₹76 Cr | ₹54 Cr | ₹60 Cr | ₹75 Cr |
| Expenses | ₹60 Cr | ₹69 Cr | ₹51 Cr | ₹59 Cr | ₹73 Cr |
| Operating Profit (Excl OI) | ₹9.38 Cr | ₹6.89 Cr | ₹2.65 Cr | ₹0.90 Cr | ₹2.08 Cr |
| Other Income | ₹2.23 Cr | ₹1.79 Cr | ₹1.81 Cr | ₹2.17 Cr | ₹1.98 Cr |
| Interest | ₹2.26 Cr | ₹2.49 Cr | ₹2.63 Cr | ₹2.56 Cr | ₹2.66 Cr |
| Depreciation | ₹0.50 Cr | ₹0.46 Cr | ₹0.43 Cr | ₹0.44 Cr | ₹0.27 Cr |
| Profit Before Tax | ₹8.85 Cr | ₹5.73 Cr | ₹1.41 Cr | ₹0.08 Cr | ₹1.13 Cr |
| Profit After Tax | ₹6.60 Cr | ₹4.02 Cr | ₹1.05 Cr | ₹0.03 Cr | ₹0.71 Cr |
| Consolidated Net Profit | ₹6.60 Cr | ₹4.02 Cr | ₹1.05 Cr | ₹0.03 Cr | ₹0.71 Cr |
| Earnings Per Share (Rs) | ₹6.26 | ₹3.82 | ₹0.99 | ₹0.03 | ₹1.08 |
| PAT Margin (%) | 9.48 | 5.31 | 1.95 | 0.05 | 0.95 |
| ROE(%) | 22.26 | 16.50 | 4.78 | 0.15 | 3.40 |
| ROCE(%) | 21.92 | 18.87 | 10.33 | 6.89 | 9.80 |
| Total Debt/Equity(x) | 0.41 | 0.79 | 0.78 | 0.78 | 0.80 |
Key Financials |
||
| Market Cap | : | ₹ 170.6 Cr |
| Revenue (TTM) | : | ₹ 80.1 Cr |
| Net Profit(TTM) | : | ₹ 5.8 Cr |
| EPS (TTM) | : | ₹ 5.5 |
| P/E (TTM) | : | 29.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VAISHALI PHARMA | -8.3% | -10.1% | -9% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
VAISHALI PHARMA Revenues
[NSE : VAISHALI]
| Y-o-Y | -8.12 % |
| 5 Yr CAGR | -1.86 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹70 Cr | -8.12 | |
| Mar2022 | ₹76 Cr | 41.00 | |
| Mar2021 | ₹54 Cr | -10.50 | |
| Mar2020 | ₹60 Cr | -19.98 | |
| Mar2019 | ₹75 Cr | - | |
VAISHALI PHARMA Operating Profit
[NSE : VAISHALI]
| Y-o-Y | 36.21 % |
| 5 Yr CAGR | 45.70 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹9.38 Cr | 36.21 | |
| Mar2022 | ₹6.89 Cr | 160.01 | |
| Mar2021 | ₹2.65 Cr | 193.90 | |
| Mar2020 | ₹0.90 Cr | -56.70 | |
| Mar2019 | ₹2.08 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 48.24 % |
| 5 Yr CAGR | 48.47 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 13.46% | 48.24 | |
| Mar2022 | 9.08% | 84.55 | |
| Mar2021 | 4.92% | 228.00 | |
| Mar2020 | 1.5% | -45.85 | |
| Mar2019 | 2.77% | - | |
VAISHALI PHARMA Profit After Tax
[NSE : VAISHALI]
| Y-o-Y | 64.12 % |
| 5 Yr CAGR | 74.39 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹6.60 Cr | 64.12 | |
| Mar2022 | ₹4.02 Cr | 284.70 | |
| Mar2021 | ₹1.05 Cr | 3,069.70 | |
| Mar2020 | ₹0.03 Cr | -95.38 | |
| Mar2019 | ₹0.71 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 78.53 % |
| 5 Yr CAGR | 77.73 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 9.48 % | 78.53 | |
| Mar2022 | 5.31 % | 172.31 | |
| Mar2021 | 1.95 % | 3,800.00 | |
| Mar2020 | 0.05 % | -94.74 | |
| Mar2019 | 0.95 % | - | |
VAISHALI PHARMA Earnings Per Share (EPS)
[NSE : VAISHALI]
| Y-o-Y | 63.87 % |
| 5 Yr CAGR | 55.16 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹6.26 | 63.87 | |
| Mar2022 | ₹3.82 | 285.86 | |
| Mar2021 | ₹0.99 | 3,200.00 | |
| Mar2020 | ₹0.03 | -97.22 | |
| Mar2019 | ₹1.08 | - | |
VAISHALI PHARMA Return on Capital Employed (ROCE)
[NSE : VAISHALI]
| Y-o-Y | 16.16 % |
| 5 Yr CAGR | 22.29 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 21.92% | 16.16 | |
| Mar2022 | 18.87% | 82.67 | |
| Mar2021 | 10.33% | 49.93 | |
| Mar2020 | 6.89% | -29.69 | |
| Mar2019 | 9.8% | - | |
VAISHALI PHARMA Share Price vs Sensex
| Current Share Price | : | ₹159.5 |
| Current MarketCap | : | ₹ 170.6 Cr |
| Updated EOD on | : | Apr 19,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -8.3% |
-10.1% |
-9% |
| SENSEX | -2.6% |
-0% |
21% |
VAISHALI PHARMA related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about VAISHALI PHARMA Financials
How the annual revenues of VAISHALI PHARMA have changed ?
The Revenues of VAISHALI PHARMA have decreased by -8.12% YoY .
How the Earnings per Share (EPS) of VAISHALI PHARMA have changed?
The Earnings Per Share (EPS) of VAISHALI PHARMA has increased by 63.87 % YoY .
Check out Intrinsic Value of Peers of VAISHALI PHARMA
Compare Stock Analytics of Peers of VAISHALI PHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
